Opus Genetics, Inc. Share Price
NASDAQ: IRD | Micro CapOpus Genetics, Inc. Stock Performance
Opus Genetics, Inc. Share Price Today
As of 30 October 2026, Opus Genetics, Inc.'s share price is $3.46. The stock opened at $3.59, compared to its previous close of $3.65. During today's trading session, Opus Genetics, Inc.'s share price traded between $3.42 and $3.60, with an average price of $3.51. Over the past 52 weeks, the stock has recorded a high of $7.05 and a low of $1.70. In terms of performance, Opus Genetics, Inc.'s share price has declined by 32.16% over the last six months and is up 51.42% on a year-on-year basis.
Opus Genetics, Inc. Share Price Chart
Opus Genetics, Inc. Quarterly Profit & Loss
All figures in USD
Opus Genetics, Inc. Annual Profit & Loss
All figures in USD
About Opus Genetics, Inc.
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.
Opus Genetics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.82 | $3.46 | -28.84% |
Sep 2026 | $3.68 | $4.86 | +25.94% |
Aug 2026 | $3.60 | $3.85 | +3.91% |
Jul 2026 | $4.05 | $3.71 | -9.95% |
Jun 2026 | $4.44 | $4.12 | -5.50% |
May 2026 | $5.15 | $4.36 | -14.51% |
Apr 2026 | $4.66 | $5.10 | +12.09% |
Mar 2026 | $4.04 | $4.55 | +9.37% |
Feb 2026 | $2.33 | $4.16 | +81.26% |
Jan 2026 | $2.27 | $2.29 | +14.46% |
Dec 2025 | $2.08 | $2.00 | -4.98% |
Nov 2025 | $2.33 | $2.11 | -7.66% |